AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $521,126 | +18.4% | 10,303 | +9.3% | 0.00% | +100.0% |
| Q2 2023 | $439,960 | +56.6% | 9,423 | +28.3% | 0.00% | 0.0% |
| Q1 2023 | $281,020 | -38.6% | 7,345 | -12.1% | 0.00% | -50.0% |
| Q4 2022 | $457,744 | +114.9% | 8,353 | +33.7% | 0.00% | +100.0% |
| Q3 2022 | $213,000 | -4.5% | 6,249 | -40.6% | 0.00% | – |
| Q4 2021 | $223,000 | -7.1% | 10,529 | -2.0% | 0.00% | -100.0% |
| Q3 2021 | $240,000 | -25.2% | 10,740 | -16.9% | 0.00% | 0.0% |
| Q2 2021 | $321,000 | +31.6% | 12,929 | +53.5% | 0.00% | 0.0% |
| Q1 2021 | $244,000 | +13.0% | 8,423 | +0.8% | 0.00% | 0.0% |
| Q4 2020 | $216,000 | -3.1% | 8,360 | +15.3% | 0.00% | 0.0% |
| Q3 2020 | $223,000 | – | 7,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $125,180,178 | 50.58% |
| COMMODORE CAPITAL LP | 790,000 | $30,225,400 | 4.60% |
| Redmile Group, LLC | 2,044,389 | $78,218,323 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 202,561 | $7,749,984 | 3.20% |
| Ghost Tree Capital, LLC | 275,000 | $10,522,000 | 3.11% |
| Avidity Partners Management LP | 2,447,000 | $93,622,220 | 3.11% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $22,736,043 | 3.08% |
| Logos Global Management LP | 400,000 | $15,304,000 | 2.19% |
| Yiheng Capital Management, L.P. | 1,125,791 | $43,072,764 | 1.70% |
| Boxer Capital, LLC | 831,495 | $31,813 | 1.56% |